NOVOZYMES BIOPHARMA DK A/S

Pharmaceutical products and additives for supporting drugs by reducing the time the body takes to break down the active ingredients of the drug; [ Chemicals used in the manufacture of pharmaceuticals ]; Research and development services in the fields of pharmaceuticals

[ Pharmaceutical products and additives for supporting a drug by reducing the time the body takes to break down the active ingredients of the drug; pharmaceutical products for extending the half-life of drugs; and pharmaceutical products, namely, proteins for extending the half-life of drugs ]; Chemicals used in industry and science; chemical additives for use in the manufacture of pharmaceuticals; chemical reagents not for medical purposes; [ proteins in raw material form for use in the manufacture of pharmaceuticals; ] chemicals comprising a synthetic triazine ligand for use as an affinity matrix for extending the half-life of a protein drug while maintaining its activity; and chemicals used for purification of albumin fusion proteins; [ Research and development services in the fields of biotechnology, biochemistry, biology, medicines and pharmaceuticals; consultancy services in the fields of biotechnology, biochemistry, biology, medicines and pharmaceuticals; advisory services in the fields of biotechnology, biochemistry, biology, medicines and pharmaceuticals; expert services, namely, consulting and research in the fields of biotechnology, biochemistry, biology, medicines and pharmaceuticals; and analysis and development services for medicines and pharmaceuticals ]

[ Reagents for scientific or research use; reagents for chemical analysis; protein arrays and nucleotide arrays for scientific and medical research; chemical preparations for use in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; and chemicals, namely, proteins and nucleic acids for use in the manufacture of pharmaceuticals, feed, foods and plants ] | [ Diagnostic reagents for clinical or medical laboratory use; contrasting agents for ultrasound diagnostic imaging; diagnostic imaging agents for the detection of the presence, location and extent of cancer; macro-aggregated albumin for in-vivo imaging, namely, lung imaging, shunt imaging and isotopic venography ] | Pharmaceutical research and development; [ professional consulting services and advice about agriculture chemistry; ] advisory services in the fields of science, biotechnology, biochemistry, biology and pharmaceuticals

RECOMBINANT HUMAN ALBUMIN FOR USE AS PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY, THERAPEUTIC AND MEDICAL DIAGNOSTIC USE, AND USE IN IN VITRO FERTILIZATION; RECOMBINANT HUMAN ALBUMIN FOR USE AS A STABILIZER/ EXCIPIENT FOR CELL CULTURE MEDIUM AND FOR THE FORMATION OF DIAGNOSTIC IMAGING AGENTS, NAMELY, MICROSPHERES AND RADIOLABELED ALBUMIN AGGREGATES